Plasma Interleukin-6 Levels Are Independently Associated With Insulin Secretion in a Cohort of Italian-Caucasian Nondiabetic Subjects

Abstract

We have investigated the relationships between plasma interleukin-6 (IL-6) levels and insulin sensitivity and insulin secretion in a cohort of Italian-Caucasian glucosetolerant subjects. Insulin sensitivity was assessed by euglycemic-hyperinsulinemic clamp, and first-phase insulin secretion was measured by intravenous glucose tolerance test. Fasting plasma IL-6 concentration was negatively correlated with the rate of insulin-stimulated glucose disposal (M) (P ‫؍‬ 0.001). The correlation remained statistically significant, while attenuated, after adjusting for sex, age, and BMI (P < 0.03); after an additional adjustment for free fatty acids (FFAs), a further attenuation was observed, but statistical significance was maintained (P < 0.044). Fasting plasma IL-6 concentration was positively correlated with first-phase insulin secretion assessed as acute insulin response (AIR) (P ‫؍‬ 0.001). The correlation remained significant after adjusting for sex, age, and BMI (P ‫؍‬ 0.003). To estimate the independent contribution of plasma IL-6 levels to AIR, we carried out forward stepwise linear regression analysis in a model that included sex, age, BMI, waist-to-hip ratio, FFAs, and insulin-stimulated glucose disposal. Only insulin sensitivity and plasma IL-6 concentration were independently associated with AIR, accounting, respectively, for 19.0 and 5.2% of its variation. These data indicate that IL-6 is associated in a reciprocal manner with the two pathophysiological components of type 2 diabetes, i.e., insulin resistance and insulin secretion. Diabetes

The −174GG Interleukin-6 Genotype Is Protective From Retinopathy and Nephropathy in Juvenile Onset Type 1 Diabetes Mellitus

“…For example, elevated IL-6 serum level has been found to be associated with higher fasting and postload insulin level in healthy human population, implying that IL-6 may encourage insulin secretion (29,30). In line with this suggestion, it was revealed that IL-6 might directly stimulate insulin secretion from rat pancreatic islets (31) as well as from cultures of these cells in vitro (32).…”

Tangeretin, a polymethoxylated flavone, modulates lipid homeostasis and decreases oxidative stress by inhibiting NF-κB activation and proinflammatory cytokines in cardiac tissue of streptozotocin-induced diabetic rats

“…Proinflammatory cytokine tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) and oxidative stress are widely recognized markers of vascular inflammation (Andreozzi et al, 2006;Kern, Ranganathan, Li, Wood, & Ranganathan, 2001;Rui et al, 2001;Singh, Devraj, & Jialal, 2005). The levels of these cytokines and oxidative stress are elevated in the blood of many diabetic patients (Jain, Kannan, Lim, McVie, & Bocchini, 2002).…”

Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice

“…The reason for this discrepancy is currently unclear. Interestingly, it was recently reported that circulating IL-6 levels correlated positively with insulin levels in man and that this was unrelated to degree of insulin resistance [47]. One possible mechanism for this could be AMPK activation by IL-6.…”